Latest Articles

Publication Date
Bayer launches phase III trial testing Mirena for uterine condition with no treatments - Indian Pharma Post

Bayer launches phase III trial testing Mirena for uterine condition with no treatments Indian Pharma Post

Published: Dec. 7, 2025, 6:02 a.m.
High cost of infertility treatments puts financial strain on couples: ICMR-NIRRCH study - The Hindu

High cost of infertility treatments puts financial strain on couples: ICMR-NIRRCH study The Hindu

Published: Dec. 5, 2025, 5:15 p.m.
Infertility management in patients with bowel endometriosis: the current landscape and the promise of randomised trials: a narrative review.

The management of infertility in women with bowel endometriosis remains a significant clinical challenge. The two primary therapeutic approaches include first-line medically assisted reproduction (MAR) and primary bowel surgery, with …

Published: Dec. 3, 2025, midnight
High inhibition ratio and transformation index of 2 mg dienogest: further evidence for its use in endometriosis treatment.

Endometriosis is a common, chronic disease with a high burden for women, characterised by the implantation of endometrial cells outside the uterus. Many different treatments have been proposed for this …

Published: Dec. 2, 2025, midnight
Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications.

For a very long time, herbal treatments have served as remedies for various humans and animals. Natural compounds typically have multiple pharmacological actions because they interact with various biological targets. …

Published: Dec. 2, 2025, midnight
Patients' knowledge, attitudes, and practices concerning endometriosis and its long-term management.

Endometriosis, affecting 10-15% of women, causes pain and infertility. Current treatments have limitations. This study aimed to investigate patients' knowledge, attitude, and practice (KAP) concerning endometriosis and its long-term management.

Published: Nov. 28, 2025, midnight
The Financial Toxicity of Endometriosis: Unseen Costs and Policy Gaps.

Endometriosis affects 1 in 10 Canadians, yet its financial toxicity remains poorly understood. While universal healthcare covers physician and hospital services, patients face substantial out-of-pocket costs for medications, complementary therapies, …

Published: Nov. 28, 2025, midnight
Personalized Vaginal Drug Delivery through 3D Printing: Techniques, Challenges, and Future Perspectives.

Vaginal disorders in reproductive‑age women, including bacterial vaginosis (affecting 23-29%), endometriosis, etc., are increasing alarmingly day by day worldwide. Vaginal drug delivery (VDD) has garnered notable attention in the pharmaceutical …

Published: Nov. 26, 2025, midnight
LJI scientists launch new investigations into breast cancer treatments and the hidden side of reproductive health - La Jolla Institute

LJI scientists launch new investigations into breast cancer treatments and the hidden side of reproductive health La Jolla Institute

Published: Nov. 19, 2025, 9:03 p.m.
Award-winning digital ‘twinning’ project to tailor treatments for endometriosis patients - Hamilton Health Sciences

Award-winning digital ‘twinning’ project to tailor treatments for endometriosis patients Hamilton Health Sciences

Published: Nov. 18, 2025, 2:23 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!